Skye Bioscience Inc Sustainability Reports
Skye Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics targeting the endocannabinoid system. Its primary programs investigate treatments for metabolic disorders, obesity, and ophthalmic indications.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493004823BTPRPZ8750
FIGI: BBG00433H0D8
2 reports from 2023 to 2024